Neutrophil/lymphocyte ratio as a predictor of cardiovascular events in incident dialysis patients: a Japanese prospective cohort study

Clinical and Experimental Nephrology

Volumn 19, Issue 4, 2015, Pages 718-724

  Abe, Tomoko ^a   Kato, Sawako ^a   Tsuruta, Yoshinari ^b   Sugiura, Sachiyo ^c   Katsuno, Takayuki ^a   Kosugi, Tomoki ^a   Tsuboi, Naotake ^a   Matsuo, Seiichi ^a   Maruyama, Shoichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Meiyo Clinic   (Japan)

^c Masuko Memorial Hospital   (Japan)

Author keywords

Cardiovascular disease; Dialysis; Inflammation; Neutrophil lymphocyte ratio

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL LYMPHOCYTE RATIO; PROSPECTIVE STUDY; RISK ASSESSMENT; AGED; BLOOD; COMPLICATION; IMMUNOLOGY; JAPAN; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE COUNT; PREDICTIVE VALUE; RENAL REPLACEMENT THERAPY;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84940437989     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1046-2     Document Type: Article

References (19)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10(7):1606–15.
2. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526–33. doi:10.2215/CJN.00950208.
3. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793–808. doi:10.1046/j.1523-1755.2003.00803.x.
4. Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martinez-Castelao A, et al. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol. 2012;8(3):141–50. doi:10.1038/nrneph.2011.170.
5. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30. doi:10.1016/j.critrevonc.2013.03.010.
6. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–60. doi:10.1016/j.atherosclerosis.2012.09.009.
7. Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171(3):390–7. doi:10.1016/j.ijcard.2013.12.019.
8. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, et al. Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One. 2013;8(2):e56745. doi:10.1371/journal.pone.0056745.
9. Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26(2):358–65. doi:10.5301/jn.5000152.
10. Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, et al. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(4):532–40. doi:10.1007/s10157-012-0728-x.
11. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11(1):8–13.
12. Okyay GU, Inal S, Onec K, Er RE, Pasaoglu O, Pasaoglu H, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35(1):29–36. doi:10.3109/0886022X.2012.734429.
13. Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM, Cicekler H, et al. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail. 2012;34(10):1229–37. doi:10.3109/0886022X.2012.723580.
14. Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7(3):166–76. doi:10.1038/nrneph.2011.2.
15. Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20(6):662–8. doi:10.1097/MNH.0b013e32834ad504.
16. Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa K, et al. C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract. 2011;117(2):c167–78. doi:10.1159/000320116.
17. Crews DC, Sozio SM, Liu Y, Coresh J, Powe NR. Inflammation and the paradox of racial differences in dialysis survival. J Am Soc Nephrol. 2011;22(12):2279–86. doi:10.1681/ASN.2011030305.
18. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 Suppl 2):S1–140.
19. de Mutsert R, Grootendorst DC, Boeschoten EW, Brandts H, van Manen JG, Krediet RT, et al. Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr. 2009;89(3):787–93. doi:10.3945/ajcn.2008.26970.